NRX Pharmaceuticals (NRXP) EPS (Basic) (2017 - 2026)
NRX Pharmaceuticals' (NRXP) quarterly EPS (Basic) came in at -$0.15 in Q1 2026, up 34.35% year-on-year from -$0.11 in Q1 2025, and up 28.78% on a QoQ basis from -$0.22 in Q4 2025.
NRX Pharmaceuticals (NRXP) EPS (Basic) (2017 - 2026) Analysis & Trends
NRX Pharmaceuticals (NRXP) has 10 years of EPS (Basic) data on file, last reported at -$0.15 in Q1 2026.
- On a quarterly basis, EPS (Basic) rose 34.35% year-over-year to -$0.15 in Q1 2026; TTM through Mar 2026 was -$0.54, a 45.52% increase from a year earlier, with the FY2025 full-year figure at -$3.15, down 33.44% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.15, up from -$0.22 in the prior quarter.
- Over the last five years, EPS (Basic) for NRXP reached as high as -$0.15 in Q1 2026 and fell as low as -$2.62 in Q1 2022.
- Historically, EPS (Basic) has averaged -$0.74 across 5 years, with a median of -$0.59 in 2023.
- Across the five-year window, EPS (Basic) jumped 98.27% in 2022 and retreated 21.88% in 2024, its largest moves.
- Year by year, EPS (Basic) stood at -$1.56 in 2022, then jumped by 62.6% to -$0.58 in 2023, then surged by 60.83% to -$0.23 in 2024, then gained by 5.36% to -$0.22 in 2025, then grew by 28.78% to -$0.15 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$0.15 in Q1 2026, -$0.22 in Q4 2025, and -$0.19 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | NRX Pharmaceuticals | 137.57 Mn | 130.87 Mn | 437,000.00 | -0.15 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.15 |
| Dec 31, 2025 | -0.22 |
| Sep 30, 2025 | -0.19 |
| Jun 30, 2025 | -0.21 |
| Mar 31, 2025 | -0.23 |
| Dec 31, 2024 | -0.23 |
| Sep 30, 2024 | -0.28 |
| Jun 30, 2024 | -0.67 |
| Mar 31, 2024 | -0.72 |
| Dec 31, 2023 | -0.58 |
| Sep 30, 2023 | -0.76 |
| Jun 30, 2023 | -1.10 |
| Mar 31, 2023 | -0.59 |
| Dec 31, 2022 | -1.56 |
| Sep 30, 2022 | -1.37 |
| Jun 30, 2022 | -1.06 |
| Mar 31, 2022 | -2.62 |
| Dec 31, 2021 | -6.48 |
| Sep 30, 2021 | -7.16 |
| Jun 30, 2021 | -61.34 |